The investment-grade notes are due 2026, 2030, 2031, 2035, 2055 and 2064

Davis Polk advised the representatives of the several underwriters on an SEC-registered offering by Elevance Health, Inc. (f/k/a Anthem, Inc.) of $5.2 billion in aggregate principal amount of unsecured and unsubordinated notes. The offering consisted of $350 million in aggregate principal amount of 4.500% notes due 2026, $750 million in aggregate principal amount of 4.750% notes due 2030, $750 million in aggregate principal amount of 4.950% notes due 2031, $1.20 billion in aggregate principal amount of 5.200% notes due 2035, $1.35 billion in aggregate principal amount of 5.700% notes due 2055 and $800 million in aggregate principal amount of 5.850% notes due 2064.

Elevance Health is one of the largest health benefits companies in the United States. Elevance Health is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent health benefit plans.

The Davis Polk corporate team included partners Joseph A. Hall and Pedro J. Bermeo and associate Dennis Chu. Partner Mario J. Verdolini and associate Constance Zhang provided tax advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post